BRIEF-AbCellera Receives Authorization From Health Canada To Initiate The Phase 1 Clinical Trial Of Abcl635 For Vasomotor Symptoms Due To Menopause

Reuters
15 May
BRIEF-AbCellera Receives Authorization From Health Canada To Initiate The Phase 1 Clinical Trial Of Abcl635 For Vasomotor Symptoms Due To Menopause

May 14 (Reuters) - Abcellera Biologics Inc ABCL.O:

  • ABCELLERA RECEIVES AUTHORIZATION FROM HEALTH CANADA TO INITIATE THE PHASE 1 CLINICAL TRIAL OF ABCL635 FOR VASOMOTOR SYMPTOMS DUE TO MENOPAUSE

  • ABCELLERA RECEIVES AUTHORIZATION FROM HEALTH CANADA TO INITIATE THE PHASE 1 CLINICAL TRIAL OF ABCL635 FOR VASOMOTOR SYMPTOMS DUE TO MENOPAUSE

  • ABCELLERA BIOLOGICS INC - PHASE 1 TRIAL FOR ABCL635 EXPECTED TO START IN Q3 2025

Source text: ID:nBw90vhPga

Further company coverage: ABCL.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10